DOJ plans to reschedule marijuana as a lower-risk drug
CNN
The Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans told CNN, a historic move that acknowledges the medical benefits of the long-criminalized drug and carries broad implications for cannabis-related research and the industry at large.
The Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans told CNN, a historic move that acknowledges the medical benefits of the long-criminalized drug and carries broad implications for cannabis-related research and the industry at large. The US Department of Justice is expected to recommend that marijuana be rescheduled as a Schedule III controlled substance, a classification shared by prescription drugs such as ketamine and Tylenol with codeine. “The DOJ continues to work on this rule. We have no further comment at this time,” an administration official said Tuesday. The move was first reported Tuesday by the Associated Press. Attorney General Merrick Garland plans to submit a draft rule to the White House Office of Management and Budget as soon as Tuesday, according to a source familiar. The standard rulemaking process is lengthy, is subject to a public comment period, and could take months to complete. For more than 50 years, marijuana has been categorized as a Schedule I substance — drugs like heroin, bath salts and ecstasy that are considered to have no accepted medical use and a high potential for abuse — and subject to the strictest of restrictions.
An average of 11,200 Americans will reach retirement age each day in 2024, according to a recent report by the Alliance for Lifetime Income. The report found that the largest number of Americans are set to turn 65 in US history this year—and that number is set to creep higher for the next three years.